Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis

<table>Forest plot with the weighted mean difference (WMD) on minimental state examination (MMSE) of Hup A relative to placebo in AD with 95% CI of the trials included in meta-analysis.</table>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis 